← Leaderboards
Nilkantha Sen
Augusta University
$3,638,738
Attributed
$3,638,738
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $733.6K · FY2016–20$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$3,638,738 · 2
By mechanism
R01$3,638,738 · 2
Top collaborators
No co-investigators on record.
Most similar at Augusta University
Same institution · by research overlap
- Ruth B. Caldwell$11,181,117
- Kumar Vaibhav$2,102,643
- Balamurali K Ambati$10,199,905
- Krishnan M. Dhandapani$9,189,716
- Manuela Bartoli$4,552,283
Others in their field
Top investigators on “Injury”
- Polly Chang · Sri International$119,352,977
- Marco Pahor · Wake Forest University Health Sciences$82,312,292
- Kerry J Kelly · New York City Fire Department$81,924,266
- Asrar B. Malik · University Of Illinois At Chicago$81,164,529
- Peter Scott Heeger · Case Western Reserve University$76,259,223
- Jacqueline Moline · Icahn School Of Medicine At Mount Sinai$75,762,106
Research focus
InjuryHydrogen SulfideAffectImpairmentNeuronsPreventTraumatic Brain InjuryCysteineProteinsMonitorMortalityMutantBaseOverexpressionFunctional DisorderSulfhydrationCell DeathCystathionine Beta-SynthaseMorbidity - Disease RateOxidative StressHypoxia Inducible Factor 1Cessation Of LifeAcuteChronic
Grant awards (10)
Molecular Mechanisms underlying vision impairment after TBI$391,250
R01 · FY2020 · EY · contact PI
Development of therapeutic strategy against TBI based on hydrogen sulfide$342,344
R01 · FY2020 · NS · contact PI
Molecular Mechanisms underlying vision impairment after TBI$391,250
R01 · FY2019 · EY · contact PI
Development of therapeutic strategy against TBI based on hydrogen sulfide$342,344
R01 · FY2019 · NS · contact PI
Molecular Mechanisms underlying vision impairment after TBI$390,417
R01 · FY2018 · EY · contact PI
Development of therapeutic strategy against TBI based on hydrogen sulfide$341,797
R01 · FY2018 · NS · contact PI
Molecular Mechanisms underlying vision impairment after TBI$387,500
R01 · FY2017 · EY · contact PI
Development of therapeutic strategy against TBI based on hydrogen sulfide$339,336
R01 · FY2017 · NS · contact PI
Molecular Mechanisms underlying vision impairment after TBI$380,000
R01 · FY2016 · EY · contact PI
Development of therapeutic strategy against TBI based on hydrogen sulfide$332,500
R01 · FY2016 · NS · contact PI